Vanguard Group’s Mural Oncology MURA Stock Holding History

Vanguard Group’s Portfolio MURA Stock Details MURA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-454,712	Closed	-$941K	–	4385
2025 Q3	$941K	Sell	454,712 -318,139	-41%	-$684K	﹤0.01%	3806
2025 Q2	$1.91M	Sell	772,851 -11,224	-1%	-$26.5K	﹤0.01%	3547
2025 Q1	$988K	Sell	784,075 -12,939	-2%	-$47.2K	﹤0.01%	3714
2024 Q4	$2.57M	Sell	797,014 -38,575	-5%	-$136K	﹤0.01%	3490
2024 Q3	$2.62M	Sell	835,589 -490	-0.1%	-$1.6K	﹤0.01%	3474
2024 Q2	$2.63M	Sell	836,079 -119,427	-12%	-$440K	﹤0.01%	3476
2024 Q1	$4.67M	Sell	955,506 -568,511	-37%	-$2.76M	﹤0.01%	3323
2023 Q4	$9.02M	Buy	+1,524,017	New	+$6.13M	﹤0.01%	3007

Vanguard Group's MURA Position: Q4 2025 in Review

Vanguard Group sold out of Mural Oncology (MURA) in Q4 2025, closing a stake of 454,712 shares — an estimated $941K sold.

Vanguard Group first reported a position in MURA in Q4 2023 and held it in 8 quarters. The position peaked at $9.02M in Q4 2023. 0 funds tracked by Wall St. Rank hold MURA as of Q4 2025.

Vanguard Group reported no remaining Mural Oncology position as of Q4 2025 after selling out during the quarter.
Vanguard Group sold 454,712 Mural Oncology shares in Q4 2025, an estimated $941K.
Vanguard Group first reported a position in Mural Oncology in Q4 2023 and held it in 8 quarters.
Vanguard Group's Mural Oncology position peaked at $9.02M in Q4 2023.
0 funds tracked by Wall St. Rank held Mural Oncology as of Q4 2025.

Based on Vanguard Group's 13F filing for Q4 2025, filed 29 Jan 2026.